How to optimize the evaluation and use of antibiotics in neonates

about

A Delphi process to optimize quality and performance of drug evaluation in neonates Clinical pharmacology of carbapenems in neonates.

P2860

Q28542934-A95673A0-3176-4D64-82E8-D9135468C038 Q38148807-227230EF-4BED-4CDD-810A-44D1EED1DA3F

P2860

How to optimize the evaluation and use of antibiotics in neonates

Item

http://www.wikidata.org/entity/Q36452369

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

How to optimize the evaluation and use of antibiotics in neonates

@ast

How to optimize the evaluation and use of antibiotics in neonates

@en

type

Item

label

How to optimize the evaluation and use of antibiotics in neonates

@ast

How to optimize the evaluation and use of antibiotics in neonates

@en

prefLabel

How to optimize the evaluation and use of antibiotics in neonates

@ast

How to optimize the evaluation and use of antibiotics in neonates

@en

P1476

How to optimize the evaluation and use of antibiotics in neonates

@en

P2093

Evelyne Jacqz-Aigrain

http://www.w3.org/2001/XMLSchema#string

Florentia Kaguelidou

http://www.w3.org/2001/XMLSchema#string

John N van den Anker

http://www.w3.org/2001/XMLSchema#string

P2860

Intrapartum antibiotics for known maternal Group B streptococcal colonization

Intrapartum antibiotics for Group B streptococcal colonisation

Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections

Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules.

New approaches to preventing, diagnosing, and treating neonatal sepsis.

Early and late onset sepsis in late preterm infants.

Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review.

Risk factors and prevention of late-onset sepsis in premature infants.

Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.

Developmental pharmacology--drug disposition, action, and therapy in infants and children.

P304

1117-1128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PCL.2012.07.004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23036247

http://www.w3.org/2001/XMLSchema#string

P932

4709255

http://www.w3.org/2001/XMLSchema#string

How to optimize the evaluation and use of antibiotics in neonates

about

P2860

P2860

How to optimize the evaluation and use of antibiotics in neonates

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932